Randomised controlled trial: Extended-duration dabigatran is non-inferior to warfarin and more effective than placebo for symptomatic VTE

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{a7036b5a2e0c45b0920b48fc98501b6a,

title = "Randomised controlled trial: Extended-duration dabigatran is non-inferior to warfarin and more effective than placebo for symptomatic VTE",

author = "Liem, {Timothy K.} and DeLoughery, {Thomas G.}",

year = "2014",

month = feb,

doi = "10.1136/eb-2013-101317",

language = "English (US)",

volume = "19",

pages = "29",

journal = "Evidence-Based Medicine",

issn = "1356-5524",

publisher = "BMJ Publishing Group",

number = "1",

}

TY - JOUR

T1 - Randomised controlled trial

T2 - Extended-duration dabigatran is non-inferior to warfarin and more effective than placebo for symptomatic VTE

AU - Liem, Timothy K.

AU - DeLoughery, Thomas G.

PY - 2014/2

Y1 - 2014/2

UR - http://www.scopus.com/inward/record.url?scp=84895559308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895559308&partnerID=8YFLogxK

U2 - 10.1136/eb-2013-101317

DO - 10.1136/eb-2013-101317

M3 - Comment/debate

C2 - 23749602

AN - SCOPUS:84895559308

SN - 1356-5524

VL - 19

SP - 29

JO - Evidence-Based Medicine

JF - Evidence-Based Medicine

IS - 1

ER -